Company overview
Fluidic Sciences offers in-solution technologies for protein interaction analysis, including the Fluidity One-M instrument using Microfluidic Diffusional Sizing (MDS) to measure binding affinity, stoichiometry, size, and concentration without immobilization in complex matrices like serum and plasma. Following its acquisition of Sphere Bio's assets in September 2025, the company provides an integrated portfolio of picodroplet microfluidic platforms, consumables, and reagents for high-throughput single-cell screening, isolation, and biologics discovery. These solutions support biotherapeutic development, cell engineering, and synthetic biology workflows.
Fluidic Sciences Ltd is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CRO & Clinical Services partner serving United States & Americas. Core focus areas include fluidic sciences, microfluidic diffusional sizing, fluidity one-m, single-cell screening, protein interaction analysis, biologics discovery.
Industry categories: Life Science Reagents, CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Fluidic Sciences Ltd include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://fluidic.com
- Categories
- Life Science Reagents, CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- fluidic sciences, microfluidic diffusional sizing, fluidity one-m, single-cell screening, protein interaction analysis, biologics discovery
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Fluidic Sciences' key technologies for protein analysis?
- The Fluidity One-M instrument uses Microfluidic Diffusional Sizing (MDS) for immobilization-free measurement of binding affinity (Kd), stoichiometry, size, and concentration directly in solution, including complex backgrounds like serum, plasma, and lysate.
- What capabilities does Fluidic Sciences offer for single-cell analysis?
- Through the acquired Sphere Bio assets, Fluidic Sciences provides picodroplet systems and the Cyto-Mine Chroma platform for high-throughput single-cell screening, isolation, monoclonality assurance, and integration with protein interaction workflows.
- What applications do Fluidic Sciences' platforms support?
- Platforms support biologics discovery and development, cell engineering, synthetic biology, and biotherapeutic research by enabling end-to-end workflows from single-cell function to molecular binding analysis.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
